Experience from Development of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Dulaglutide for Treatment of Type 2 Diabetes Mellitus
2013 ◽
Vol 15
(8)
◽
pp. 770-773
◽
2019 ◽
Vol 43
(5)
◽
pp. 653-662
2017 ◽
Vol 55
(08)
◽
pp. 650-658